MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$324,907K
Accounts receivable
$133,113K
Short-term investments
$61,352K
Inventory
$25,518K
Prepaid expenses and
other current assets
$24,546K
Total current assets
$569,436K
Intangible assets, net
$254,154K
Long-term investments
$34,353K
Other assets
$16,181K
Operating lease
right-of-use assets
$12,647K
Property and equipment,
net
$2,412K
Restricted cash
$1,733K
Total assets
$890,916K
Total liabilities and
stockholders equity
$890,916K
Total liabilities
$648,422K
Total stockholders
equity
$242,494K
Accumulated deficit
-$1,457,699K
Accumulated other
comprehensive (loss) income
-$28K
Convertible notes payable,
net, noncurrent
$310,251K
Total current
liabilities
$272,824K
Holdback liabilities,
noncurrent
$48,257K
Operating lease
liabilities, noncurrent
$11,175K
Other liabilities
$5,915K
Additional paid-in capital
$1,700,215K
Common stock, 0.0001
par value...
$6K
Accrued expenses and
other current...
$187,625K
Accounts payable
$59,399K
Holdback liabilities,
current
$25,800K
Back
Back
Balance Sheet
Mirum Pharmaceuticals, Inc. (MIRM)
Mirum Pharmaceuticals, Inc. (MIRM)
source: myfinsight.com